131 related articles for article (PubMed ID: 9272114)
1. Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells.
Poulain L; Sichel F; Crouet H; Bureau F; Gauduchon P; Gignoux M; Le Talaër JY
Cancer Chemother Pharmacol; 1997; 40(5):385-90. PubMed ID: 9272114
[TBL] [Abstract][Full Text] [Related]
2. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
[TBL] [Abstract][Full Text] [Related]
3. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.
Kikkawa F; Kojima M; Oguchi H; Maeda O; Ishikawa H; Tamakoshi K; Mizuno K; Kawai M; Suganuma N; Tomoda Y
Anticancer Res; 1993; 13(4):891-6. PubMed ID: 8352556
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.
Assem M; Bonvalot S; Beltramo JL; Garrido C; Dimanche-Boitrel MT; Genne P; Rebibou JM; Caillot D; Chauffert B
Br J Cancer; 1994 Oct; 70(4):631-5. PubMed ID: 7917908
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
Ferguson PJ; Currie C; Vincent MD
Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide.
Marklund L; Henriksson R; Grankvist K
Int J Cancer; 2001 Aug; 93(4):577-83. PubMed ID: 11477563
[TBL] [Abstract][Full Text] [Related]
7. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
Kojima M; Kikkawa F; Oguchi H; Mizuno K; Maeda O; Tamakoshi K; Ishikawa H; Kawai M; Suganuma N; Tomoda Y
Eur J Cancer; 1994; 30A(6):773-8. PubMed ID: 7917536
[TBL] [Abstract][Full Text] [Related]
8. Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours.
Sargent JM; Elgie AW; Williamson CJ; Taylor CG
Br J Cancer; 1996 Dec; 74(11):1730-3. PubMed ID: 8956785
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
10. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
[TBL] [Abstract][Full Text] [Related]
11. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) by amphotericin B in BALB/c nude mice bearing human ovarian carcinoma cells.
Kojima M; Kikkawa F; Oguchi H; Tamakoshi K; Maeda O; Suganuma N; Tomoda Y
Jpn J Cancer Res; 1994 Nov; 85(11):1159-64. PubMed ID: 7829402
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N
Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA
Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385
[TBL] [Abstract][Full Text] [Related]
15. Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Hernlund E; Hjerpe E; Avall-Lundqvist E; Shoshan M
Mol Cancer Ther; 2009 Jul; 8(7):1916-23. PubMed ID: 19567816
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
Jones M; Siracky J; Kelland LR; Harrap KR
Br J Cancer; 1993 Jan; 67(1):24-9. PubMed ID: 8427780
[TBL] [Abstract][Full Text] [Related]
17. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.
Holloway RW; Mehta RS; Finkler NJ; Li KT; McLaren CE; Parker RJ; Fruehauf JP
Gynecol Oncol; 2002 Oct; 87(1):8-16. PubMed ID: 12468336
[TBL] [Abstract][Full Text] [Related]
18. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
[TBL] [Abstract][Full Text] [Related]
19. Reversal of cisplatin resistance with amphotericin B in a non-small cell lung cancer cell line.
Morikage T; Bungo M; Inomata M; Yoshida M; Ohmori T; Fujiwara Y; Nishio K; Saijo N
Jpn J Cancer Res; 1991 Jun; 82(6):747-51. PubMed ID: 1649814
[TBL] [Abstract][Full Text] [Related]
20. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
